Elisabeth Wedege

2.7k total citations
63 papers, 2.3k citations indexed

About

Elisabeth Wedege is a scholar working on Epidemiology, Microbiology and Molecular Biology. According to data from OpenAlex, Elisabeth Wedege has authored 63 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 45 papers in Microbiology and 10 papers in Molecular Biology. Recurrent topics in Elisabeth Wedege's work include Bacterial Infections and Vaccines (45 papers), Pneumonia and Respiratory Infections (41 papers) and Influenza Virus Research Studies (7 papers). Elisabeth Wedege is often cited by papers focused on Bacterial Infections and Vaccines (45 papers), Pneumonia and Respiratory Infections (41 papers) and Influenza Virus Research Studies (7 papers). Elisabeth Wedege collaborates with scholars based in Norway, Finland and United States. Elisabeth Wedege's co-authors include Einar Rosenqvist, E. Arne Høiby, L O Frøholm, G Bjune, Dominique A. Caugant, Klaus Bryn, Terje E. Michaelsen, Rolf Dalseg, Jan Kolberg and Ellen Namork and has published in prestigious journals such as Journal of Clinical Investigation, Biochemical and Biophysical Research Communications and Journal of Clinical Microbiology.

In The Last Decade

Elisabeth Wedege

61 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Wedege Norway 28 1.9k 1.7k 340 294 171 63 2.3k
C C Peeters Netherlands 18 1.2k 0.6× 1.3k 0.7× 271 0.8× 235 0.8× 122 0.7× 26 1.7k
J Y Tai United States 21 874 0.5× 809 0.5× 273 0.8× 378 1.3× 136 0.8× 29 1.6k
Janet K. Dykes United States 19 1.4k 0.7× 1.5k 0.9× 263 0.8× 169 0.6× 72 0.4× 40 2.2k
Sally A. Quataert United States 21 1.2k 0.6× 1.6k 0.9× 550 1.6× 206 0.7× 139 0.8× 48 2.3k
Eirik Holten Norway 19 1.4k 0.8× 1.2k 0.7× 160 0.5× 259 0.9× 48 0.3× 45 1.7k
L.A.E. Ashworth United Kingdom 26 644 0.3× 545 0.3× 236 0.7× 393 1.3× 155 0.9× 51 1.4k
Mary C. Gray United States 26 1.2k 0.6× 449 0.3× 247 0.7× 849 2.9× 81 0.5× 56 1.9k
Giorgio Fedele Italy 26 674 0.4× 721 0.4× 647 1.9× 242 0.8× 53 0.3× 62 1.8k
Kristín Jónsdóttir Norway 22 455 0.2× 546 0.3× 117 0.3× 288 1.0× 56 0.3× 54 1.5k
Howard V. Raff United States 22 277 0.1× 524 0.3× 745 2.2× 347 1.2× 359 2.1× 37 1.7k

Countries citing papers authored by Elisabeth Wedege

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Wedege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Wedege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Wedege more than expected).

Fields of papers citing papers by Elisabeth Wedege

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Wedege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Wedege. The network helps show where Elisabeth Wedege may publish in the future.

Co-authorship network of co-authors of Elisabeth Wedege

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Wedege. A scholar is included among the top collaborators of Elisabeth Wedege based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Wedege. Elisabeth Wedege is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wedege, Elisabeth, Vincent Weynants, Alfred Halstensen, et al.. (2013). Meningococcal Omp85 in Detergent‐Extracted Outer Membrane Vesicle Vaccines Induces High Levels of Non‐Functional Antibodies in Mice. Scandinavian Journal of Immunology. 77(6). 452–459. 5 indexed citations
2.
Wedege, Elisabeth, et al.. (2012). Molecular characterization of clinical and environmental isolates of Legionella pneumophila in Norway, 2001–2008. Scandinavian Journal of Infectious Diseases. 45(1). 59–64. 7 indexed citations
3.
Vainio, Kirsti, Helvi Holm Samdal, Gabriel Ånestad, et al.. (2008). Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts. European Journal of Clinical Microbiology & Infectious Diseases. 27(6). 461–465. 17 indexed citations
4.
Sprong, Tom, Anne‐Sophie W. Møller, Anna Bjerre, et al.. (2004). Complement Activation and Complement-Dependent Inflammation byNeisseria meningitidisAre Independent of Lipopolysaccharide. Infection and Immunity. 72(6). 3344–3349. 44 indexed citations
5.
Wedege, Elisabeth. (2003). Immunoblot Analysis of Sera from Patients and Vaccinees. Humana Press eBooks. 66. 275–288. 16 indexed citations
6.
Wedege, Elisabeth, Betsy Kuipers, Harry van Dijken, et al.. (2003). Antibody Specificities and Effect of Meningococcal Carriage in Icelandic Teenagers Receiving the Norwegian Serogroup B Outer Membrane Vesicle Vaccine. Infection and Immunity. 71(7). 3775–3781. 20 indexed citations
7.
Kuipers, Betsy, Germie van den Dobbelsteen, Elisabeth Wedege, & Loek van Alphen. (2003). Serological Characterization. Humana Press eBooks. 67. 131–145. 8 indexed citations
8.
Bjerre, Anna, Berit Brusletto, Tom Eirik Mollnes, et al.. (2002). Complement Activation Induced by PurifiedNeisseria meningitidisLipopolysaccharide (LPS), Outer Membrane Vesicles, Whole Bacteria, and an LPS‐Free Mutant. The Journal of Infectious Diseases. 185(2). 220–228. 39 indexed citations
9.
Wedege, Elisabeth, et al.. (2000). IgG antibody levels to meningococcal porins in patient sera: comparison of immunoblotting and ELISA measurements. Journal of Immunological Methods. 244(1-2). 9–15. 13 indexed citations
10.
Berstad, Aud Katrine Herland, Svein Rune Andersen, Rolf Dalseg, et al.. (2000). Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine. Vaccine. 18(18). 1910–1919. 29 indexed citations
11.
12.
Dalseg, Rolf, et al.. (1999). Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice. Vaccine. 17(19). 2336–2345. 43 indexed citations
13.
Haneberg, Bjørn, Rolf Dalseg, Fredrik Oftung, et al.. (1998). Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant.. PubMed. 92. 127–33. 23 indexed citations
14.
Rosenqvist, Einar, E. Arne Høiby, Elisabeth Wedege, Barica Kušećek, & Mark Achtman. (1993). The 5C Protein of Neisseria meningitidis Is Highly Immunogenic in Humans and Induces Bactericidal Antibodies. The Journal of Infectious Diseases. 167(5). 1065–1073. 81 indexed citations
15.
Rosenqvist, Einar, E. Arne Høiby, Elisabeth Wedege, et al.. (1993). A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine. Microbial Pathogenesis. 15(3). 197–205. 32 indexed citations
16.
Høiby, E. Arne, G Bjune, L O Frøholm, et al.. (1991). The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis.. PubMed. 14(2). 107–21; discussion 121. 14 indexed citations
17.
Sjursen, Haakon, Elisabeth Wedege, Einar Rosenqvist, et al.. (1990). IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination. Apmis. 98(7-12). 1061–1069. 27 indexed citations
18.
Mæland, Johan A. & Elisabeth Wedege. (1989). Serum antibodies to cross‐reactive Neisseria outer membrane antigens in healthy persons and patients with meningococcal disease. Apmis. 97(7-12). 774–780. 35 indexed citations
19.
Wedege, Elisabeth & R. Lund Karlsen. (1982). Regional Distribution of Perchloric Acid Soluble Proteins during the Development of Rat Brain. Developmental Neuroscience. 5(2-3). 156–165.
20.
Husby, Gunnar, et al.. (1977). Antibodies to human caudate nucleus neurons in Huntington's chorea.. Journal of Clinical Investigation. 59(5). 922–932. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C C Peeters Breakdown of academic impact, for papers by J Y Tai Breakdown of academic impact, for papers by Janet K. Dykes Breakdown of academic impact, for papers by Sally A. Quataert Breakdown of academic impact, for papers by Eirik Holten Breakdown of academic impact, for papers by L.A.E. Ashworth Breakdown of academic impact, for papers by Mary C. Gray Breakdown of academic impact, for papers by Giorgio Fedele Breakdown of academic impact, for papers by Kristín Jónsdóttir Breakdown of academic impact, for papers by Howard V. Raff
Rankless by CCL
2026